Real Chemistry
The Real Chemistry Podcast
Modern medicine is advancing at faster speeds than ever before, yet the world still sees the healthcare experience as difficult and dated. The Real Chemistry Podcast shares interviews with industry leaders who are innovating in healthcare. Join Real Chemistry’s Chief Marketing Officer Aaron Strout as he explores how AI and ideas can come together to transform healthcare into what it should be.
Koniecznie odwiedź stronę podcastu i wesprzyj twórcę: www.realchemistry.com
Autor
Real Chemistry
Kategoria
Strona podcastu
Ostatni odcinek
7 maj 2025
Gdzie słuchać?
Podcasty w aplikacji Replaio Radio Już wkrótcePodcasty trafią do aplikacji już wkrótce. Zainstaluj teraz i jako pierwszy zobacz nowe podejście do podcastów
Odcinki
Transforming How Patients Manage Chronic Conditions: Waqaas Al-Siddiq, Biotricity 11.05.2023 25:45
In this episode with Biotricity CEO and Founder Waqaas Al-Siddiq, PhD, discover how AI is transforming healthcare and how Biotricity's Bioheart device is helping to manage and prevent cardiac conditions.
Using Effective Communication to Build Strong Bridges: Sally Susman, Pfizer & Jim Weiss, Real Chemistry 04.05.2023 49:11
Communication is a critical skill for leaders and company culture. In this episode, Real Chemistry Founder and Chairman Jim Weiss is joined by Sally Susman, Chief Corporate Affairs Officer of Pfizer and author of "Breaking Through," who shares her insights on the importance of communication in leadership, building corporate and product brands, and navigating challenging conversations.
Delivering Personalized Care for Chronic Health Conditions: Live from SXSW 2023 with Lee Shapiro 27.04.2023 27:31
Recorded live from SXSW 2023, 7wire Ventures Co-Founder & Managing Partner Lee Shapiro explores how technology, data and collaboration can be used to make healthcare more personalized, efficient and cost-effective, ultimately leading to improved health outcomes.
Generative AI: Oh God What Now?: Live from SXSW 2023 20.04.2023 33:49
With tools like ChatGPT and DALL-E dominating news cycles, many people – especially those working in creative jobs – are wondering if they will soon be replaced by the technology known as generative AI. During this session, originally recorded in front of a live audience at SXSW 2023, Sameer Grover, CNS Sr. Specialty Division Manager at AbbVie, and Romain Bogaerts, Director of AI Product Managemen...
Becoming a Change Agent through Impactful Disruption: Live from SXSW 2023 with GSK’s Alison Woo 13.04.2023 26:11
Recorded live from SXSW 2023, Alison Woo, Head of Strategy, Planning and Paid Campaigns, Communications & Government Affairs at GSK, shares what a day in her life looks like, what she gathered at SXSW this year and what it means to be disruptive at a company without being too disruptive.
A Day in the Life of a Biopharmaceutical Leader: Live from SXSW 2023 06.04.2023 42:12
This presentation, originally recorded in front of a live audience at SXSW 2023, showcases key stories and perspectives on what a day in the life of a leader at Bristol-Myers Squibb looks like. From their experiences and challenges to how their focus on patients drives them to continue to strive in their role during these truly complicated times. Panelists: Dr. Rosanna Ricafort, Vice President, Ce...
Innovating Data Approaches for Clinical Trial Recruitment: Live from SXSW 2023 30.03.2023 47:15
This panel, originally recorded in front of a live audience at SXSW 2023, discusses innovative data sources for clinical trial recruitment and how to maximize their effectiveness. The panel explores a range of innovative data sources, such as online platforms, real world data and social networks, and how they can be used to find the right candidates for a study. The panelists discuss the advantage...
Understanding Trends to Shape our Future Normal: Rohit Bhargava, Founder & Chief Trend Curator, Non-Obvious Company 23.03.2023 28:52
Recorded live from SXSW 2023, Founder & Chief Trend Curator of the Non-Obvious Company Rohit Bhargava joins us to discuss why he continues to come back to SXSW, how the event has evolved and his new book co-authored with Henry Coutinho-Mason, The Future Normal, which leans into healthcare trends.
Changing the Relationship of Underserved Populations with Clinical Trials: Dr. Keolu Fox, Co-Founder, Native BioData Consortium & Assistant Professor, University of California, San Diego 02.03.2023 34:24
Indigenous futurist and technologist Dr. Keolu Fox joins us this week to discuss how increased diversity in clinical trials can transform healthcare for underserved populations and for the overall healthcare system.
Building a Community of Caregivers: Andrew Parker, CEO & Founder, Papa 16.02.2023 33:24
This week, CEO & Founder of Papa Andrew Parker joins the podcast and discusses how his company is empowering a new kind of healthcare built on human connection. Papa, a platform that connects older adults with Pals who provide companionship and assistance, seeks to address the caregiving shortage and support the US healthcare system’s Triple Aim.
Addressing a New Wave of Healthcare Challenges: Annalisa Jenkins, Compass Pathways & Jim Weiss, Real Chemistry 12.01.2023 38:35
Annalisa Jenkins, MBBS, Non Executive Director at Compass Pathways & Jim Weiss, Founder and Chairman at Real Chemistry, join the podcast this week to discuss women in life sciences leadership roles, novel approaches to disease areas such as infectious diseases and cancer, and using AI for a more effective healthcare system.
Breaking Down Healthcare Industry Barriers: Chas Bountra, PhD, Pro Vice-Chancellor for Innovation & Professor for Translational Medicine, University of Oxford & Jim Weiss, Founder & CEO, Real Chemistry 05.01.2023 36:34
Chas Bountra, PhD, Pro Vice-Chancellor for Innovation & Professor for Translational Medicine at the University of Oxford, and Jim Weiss, Founder & CEO of Real Chemistry, join this week’s episode to discuss accelerating healthcare through novel ideas and the importance of collaborating across organizations, industries and countries.
Democratizing Access to Healthcare: Pranam Ben, Founder & CEO, The Garage 15.12.2022 28:23
Founder and CEO of The Garage, Pranam Ben, joins us to discuss the future of value-based care and The Garage’s approach of using technology and data to solve for equity and access issues facing the healthcare industry. Read The Garage’s blog post, Tiny Tasty Morsels, to learn about their Quintuple Aim approach to change healthcare for good.
Building the Future of HEOR: Christopher Boone, PhD, VP & Global Head of HEOR, AbbVie 08.12.2022 29:23
In this week’s episode, Christopher Boone, PhD, VP & Global Head of Health Economic Outcomes and Research (HEOR) at AbbVie, discusses the changing landscape of HEOR, the importance of leadership, collaboration and innovation in the pharmaceutical industry, and the story behind his Twitter handle, DataHippie.
Improving Patient Care through Better Data Interoperability: Frank Harvey, CEO, Surescripts 01.12.2022 18:18
In this week’s episode, Surescripts CEO Frank Harvey discusses how Surescripts is improving healthcare data interoperability and better empowering pharmacists to provide primary care to patients.
Harnessing the Human Approach: Harpreet Sood, MD, VP, Primary Care & Clinical Partnerships, Huma 24.11.2022 25:48
Huma VP of Primary Care & Clinical Partnerships Harpreet Sood, MD discusses shifts in the digital health market and how Huma differentiates itself through a focus on patient centricity and collaboration across healthcare systems and teams.
Simplifying Medicine with Technology: Matt Titus, VP & Chief Commercial Officer, epocrates 10.11.2022 21:28
Data and technology should make physicians’ lives simpler, not more complicated. Matt Titus, VP & Chief Commercial Officer, epocrates, shares how his team is making an impact.
Advocating for Patients: Elle Cole, Founder of Cleverly Changing, Patient Advocate & Author 03.11.2022 16:01
Working toward creating better patient outcomes and experiences is something we have in common with Elle Cole, Founder of Cleverly Changing, Patient Advocate & Author.
Assessing the State of COVID-19: Monica Gandhi MD, MPH, Professor of Medicine, UCSF 27.10.2022 32:25
The doctor will see you now! Monica Gandhi, MD, MPH, Professor of Medicine, UCSF, is back on the show, and she’s talking about all things COVID-19, flu, and vaccines.
Investing in Marketing & Analytics: Mark Stouse, Chairman & CEO, Proof 20.10.2022 27:22
Investing in marketing and analytics is critical to navigating your organization successfully. Mark Stouse, Chairman & CEO of Proof, and Jim Weiss, Founder & Chairman of Real Chemistry, join the show to discuss this and the current state of marketing.
Advancing Health Equity: Mary Stutts, Chief Global Health Equity & Inclusion Officer, Real Chemistry 13.10.2022 31:15
Mary Stutts, Real Chemistry’s Chief Global Health Equity and Inclusion Officer, is back on the show to discuss why investing in health equity makes our industry more inclusive, digitally driven, equitable, and, ultimately, more profitable.
Addressing Aging: Juliette Han, PhD, COO & CFO, Cambrian BioPharma 06.10.2022 34:15
Addressing aging is a challenge that our client Juliette Han, PhD, COO and CFO of Cambrian BioPharma, welcomes because it's universal. Learn how Dr. Han and her team are aiming to increase "healthspan."
Accelerating the American Cancer Society’s Mission: Alice Lin Pomponio, Managing Director, BrightEdge Fund 08.09.2022 38:34
This week’s guest is dedicated to accelerating the American Cancer Society’s (ACS) mission. Alice Lin Pomponio joins the show to discuss how the BrightEdge Fund accelerates the ACS’ goal to reduce cancer mortality, end pain and suffering, and advance health equity. Plus, she shares her love of a hit Broadway musical.
Accelerating Diversity & Inclusion: Marcus Sawyerr, Founder & CEO, EQ Community 01.09.2022 34:23
Marcus Sawyerr, Founder & CEO of EQ Community, rejoins the show, but a lot has changed since the last time we spoke, like his mission to accelerate diversity and inclusion. And some things have remained the same, like his appreciation of JAY-Z.
Revolutionizing Neurodiagnostics and Brain Therapeutics: Mary Lou Jepsen, Ph.D., CEO & Founder, Openwater 04.08.2022 39:43
Inventor, trailblazer and one of the 100 most influential people in the world, according to TIME Magazine, Mary Lou Jepsen, Ph. D., joins the show. She shares how her company, Openwater, is changing the game in neurotherapeutics and why she'd want a record player on a deserted island. Learn more about this incredible work via Dr. Jepsen’s Life Itself talk.
Podobne podcasty
Replaio nie jest wydawcą podcastów; nazwy audycji, okładki i audio należą do ich autorów i są rozpowszechniane przez publiczne kanały RSS